Ligand Pharmaceuticals Director Sells 467 Shares at $195.91

Ligand Pharmaceuticals Inc (LGND) Director John Kozarich sold 467 shares on February 2, 2026, now owning 43,187 shares. The company focuses on developing or acquiring technologies for pharmaceutical companies. Over the past year, Kozarich has sold 4,203 shares and not purchased any. The stock has a price-earnings ratio of 95.81, higher than the industry median and historical median. Ligand Pharmaceuticals Inc has a price-to-GF-Value ratio of 1.54, indicating the stock is significantly overvalued.